Xuan Marian Thai

Array ( [id] => 5391691 [patent_doc_number] => 20090209004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'HUMAN IL-1 BETA ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/428558 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13794 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209004.pdf [firstpage_image] =>[orig_patent_app_number] => 12428558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479565 [patent_doc_number] => 20090202522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Use of goat serum for veterinary treatment' [patent_app_type] => utility [patent_app_number] => 12/384681 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2833 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202522.pdf [firstpage_image] =>[orig_patent_app_number] => 12384681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8625288 [patent_doc_number] => 08357783 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'Human anti-mesothelin monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 12/934060 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 22874 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12934060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373622 [patent_doc_number] => 20090311183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METALLOPROTEINASE 12 BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/397258 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 52296 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311183.pdf [firstpage_image] =>[orig_patent_app_number] => 12397258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514330 [patent_doc_number] => 20090214636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Imaging and Therapeutic Method Using Monocytes' [patent_app_type] => utility [patent_app_number] => 12/391981 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10884 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214636.pdf [firstpage_image] =>[orig_patent_app_number] => 12391981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000525 [patent_doc_number] => 20110117011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'NEUTRALIZING PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) VARIANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/989404 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 32835 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117011.pdf [firstpage_image] =>[orig_patent_app_number] => 12989404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570254 [patent_doc_number] => 20090253632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Therapeutic peptides and method' [patent_app_type] => utility [patent_app_number] => 12/320707 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22574 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253632.pdf [firstpage_image] =>[orig_patent_app_number] => 12320707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479578 [patent_doc_number] => 20090202535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Method for neutralizing effects of sPLA2' [patent_app_type] => utility [patent_app_number] => 12/320436 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3325 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202535.pdf [firstpage_image] =>[orig_patent_app_number] => 12320436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502214 [patent_doc_number] => 20090162902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'ANTIBODY WITH PROTEIN A SELECTIVITY' [patent_app_type] => utility [patent_app_number] => 12/356241 [patent_app_country] => US [patent_app_date] => 2009-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9947 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162902.pdf [firstpage_image] =>[orig_patent_app_number] => 12356241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550307 [patent_doc_number] => 08062639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Antibodies to bufalin prevent inhibition of Na/K ATPase and prolong survival in shock' [patent_app_type] => utility [patent_app_number] => 12/319967 [patent_app_country] => US [patent_app_date] => 2009-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9889 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/062/08062639.pdf [firstpage_image] =>[orig_patent_app_number] => 12319967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7519041 [patent_doc_number] => 07973143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 12/341520 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16833 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973143.pdf [firstpage_image] =>[orig_patent_app_number] => 12341520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070128 [patent_doc_number] => 20110044978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHOD FOR TREATING BONE FRACTURE' [patent_app_type] => utility [patent_app_number] => 12/811171 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14649 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044978.pdf [firstpage_image] =>[orig_patent_app_number] => 12811171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8876012 [patent_doc_number] => 08470978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Method for separating viable cells, apoptotic and dead cells' [patent_app_type] => utility [patent_app_number] => 12/746269 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 12528 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379355 [patent_doc_number] => 20090191194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'INHIBITION OF PROTEIN KINASE C ALPHA FOR THE TREATMENT OF CARDIOVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/325930 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10768 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191194.pdf [firstpage_image] =>[orig_patent_app_number] => 12325930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534849 [patent_doc_number] => 07872106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Sclerostin-binding antibodies' [patent_app_type] => utility [patent_app_number] => 12/276889 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 51083 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872106.pdf [firstpage_image] =>[orig_patent_app_number] => 12276889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563658 [patent_doc_number] => 20090136510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof' [patent_app_type] => utility [patent_app_number] => 12/313589 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20016 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136510.pdf [firstpage_image] =>[orig_patent_app_number] => 12313589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343510 [patent_doc_number] => 20100330095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'AXL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/742546 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 28219 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330095.pdf [firstpage_image] =>[orig_patent_app_number] => 12742546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104231 [patent_doc_number] => 08153766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Monoclonal antibodies against activated protein C' [patent_app_type] => utility [patent_app_number] => 12/257706 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 11620 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153766.pdf [firstpage_image] =>[orig_patent_app_number] => 12257706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435513 [patent_doc_number] => 20090170100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Biomarkers and detection methods for gastric diseases' [patent_app_type] => utility [patent_app_number] => 12/230585 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11415 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170100.pdf [firstpage_image] =>[orig_patent_app_number] => 12230585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945106 [patent_doc_number] => 20110105726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'ANTIBODIES TO HSDEK49 POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/198817 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 280051 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105726.pdf [firstpage_image] =>[orig_patent_app_number] => 12198817 [rel_patent_id] =>[rel_patent_doc_number] =>)